This inventor holds 2 USPTO granted patents. Top assignee: Johns Hopkins University. Active years: 2000-2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2000-2002
Title: Innovations by Inventor Shau-Ku Huang
Introduction
Shau-Ku Huang is a notable inventor based in Towson, MD (US). He has made significant contributions to the field of medical science, particularly in the development of innovative therapies and vaccines. With a total of 2 patents, his work focuses on addressing critical health issues through advanced technologies.
Latest Patents
Huang's latest patents include groundbreaking research on the oral delivery of nucleic acid vaccines by particulate complexes. This innovative approach utilizes nanoparticle coacervates of nucleic acids and polycations, which serve as effective vaccines when administered orally. These vaccines can induce immunity to a variety of disease-causing agents and raise a protective response to allergens. Another significant patent involves therapy for allergic diseases, where the administration of an expression gene construct for IFN-.gamma. to an affected organ is shown to be an effective means of reversing antigen-induced inflammation. This therapy is suitable for treating allergic diseases such as atopic asthma, rhinitis, and dermatitis.
Career Highlights
Shau-Ku Huang is affiliated with Johns Hopkins University, where he continues to advance his research and contribute to the scientific community. His work has garnered attention for its potential to revolutionize treatment methods for various health conditions.
Collaborations
Huang collaborates with esteemed colleagues, including Krishnendu Roy and Kam W Leong, who share his commitment to innovation in medical research.
Conclusion
Shau-Ku Huang's contributions to the field of medical science through his patents and research are noteworthy. His innovative approaches to vaccine delivery and allergy treatment highlight the importance of continued research and development in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
